Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

A 'new era' in malaria control has begun with a vaccination campaign for children in Ivory Coast

Health workers in Ivory Coast have begun giving children the latest malaria vaccine

The Independent UK

US service sector shrinks for first time since May 2020; UK private sector growth slows in ‘pre-election seize up’ – as it happened

Eurozone private sector also loses momentum

The Guardian - UK

Can I take antihistamines everyday? More than the recommended dose? What if I’m pregnant? Here’s what the research says

Allergies happen when your immune system overreacts to a normally harmless substance like dust or pollen. Hay fever, hives and anaphylaxis are all types of allergic reactions.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

As big pharma exits Nigeria, asthma patients face spiralling costs

Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.

Al Jazeera

New RSV shots tied to rare nervous system disorder — should you worry?

There's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But health officials still recommend that this population get the shots, in consultation with their doctors.

LiveScience

3 Value Stocks to Buy for Bargain Hunters

Amid macroeconomic challenges like high inflation, recession threats, and global uncertainties, value stocks such as GSK (GSK), Expedia Group (EXPE), and Albertsons (ACI) offer promising opportunities for savvy bargain hunters. Read on.

StockNews.com

FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble

BP and Shell shares today hindered FTSE 100 progress after oil prices fell to their lowest level since February.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Guillain-Barre Syndrome 'More Common Than Expected' In RSV Vaccinated Older Adults: CDC

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

Medical Daily

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

StockNews.com

FTSE 100 Live 17 May: LandSec shares fall on results, GSK in £1.25bn final Haleon stake sale

GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results.

Evening Standard

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

The Guardian - UK

Could better asthma inhalers help patients, and the planet too?

Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution and allergens.

WEKU

3 Popular Pharma Stocks Worth Buying Now

The pharmaceutical industry is set for solid growth due to increased demand for effective treatments for regular and rare diseases, an aging population, and ongoing innovations in pharma technology. Hence, investors could consider buying quality pharmaceutical stocks such as Collegium Pharmaceutical (COLL), Novo Nordisk (NVO), and GSK (GSK). Read on.

StockNews.com

FTSE 100 Live 1 May: US Fed notes ‘lack of further progress’ on inflation as it holds interest rates

Forecast-beating results by Shell and Standard Chartered today boosted their shares during another robust session for the FTSE 100 index.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

GSK Settles California Lawsuit On Zantac Heartburn Drug

GSK reaches settlement in California lawsuit related to Zantac amidst ongoing legal challenges over cancer risks.

StockNews.com

3 Pharma Stocks to Anchor Your Portfolio

The pharma market is poised to thrive due to the continuous medicinal advancements to meet the escalating demand for chronic disease treatment, technological advancements, and increased research and development. Given this backdrop, quality pharma stocks Procaps Group S.A. (PROC), Supernus Pharmaceuticals (SUPN), and GSK plc (GSK) could be wise portfolio…

International Business Times

30 Most Powerful Women In Business: The Titans Of Industry

Here are the women, who are forging paths and breaking barriers across industries, showcasing exceptional leadership and innovation.

Evening Standard

GSK’s Julie Brown to join drinks giant Diageo’s board

Guinness and Smirnoff vodka maker Diageo has appointed Julie Brown as a non-executive director with effect from August 5.

Barchart

1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

1 … 7 8 9 10

People

Shemara Wikramanayake

14 stories

Abigail Johnson

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.